OR7E108P

Across TCGA pan-cancer cohorts, OR7E108P RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of OR7E108P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR7E108P RNA is repressed in tumor relative to normal tissue. In most cancer types OR7E108P is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, THCA, and KIRP are the cancer types where OR7E108P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E108P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	−0.262	<.001	12	view →
THCA	All	II,III,IV	−0.219	<.001	11	view →
KIRP	All	All	−0.194	<.001	8	view →
LUSC	All	All	+0.302	<.001	6	view →
UCEC	All	All	+0.421	.004	2	view →
PRAD	All	All	−0.103	.003	2	view →
BRCA	Female	All	+0.066	.044	2	view →
KICH	All	III,IV	−0.390	.027	1	view →
ESCA	All	All	−0.176	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

OR7E108P–KIRC

Open the KIRC breakdown →